In a study by Pruitt et al., the transfection of anti-CTLA-4 antibody into DCs enhanced the activity of cytotoxic T lymphocytes (CTLs), which contributed to the inhibition of breast cancer cell growth (25). This evidence concerns the gene CTLA4 and breast cancer.